Inactive Instrument
Eidos Therapeutics, Inc. Stock
Stocks
EIDX
US28249H1041
Biotechnology & Medical Research
| 1 day | -4.85% |
| Manager | Title | Age | Since |
|---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 47 | 2016-02-29 |
Jonathan Fox
PSD | President | 68 | 2016-09-30 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 69 | 2016-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan A. Barr
BRD | Director/Board Member | - | 2021-01-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21-01-25 | Issuer sale | Director | 86,112 | 0.2216% | ||
| 21-01-25 | Tender | Director | 113,325 | 0.2916% | ||
| 21-01-25 | Buy | Company | 14,428,836 | 37.1285% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.85% | -4.63% | - | - | 4.75B | |
| +1.44% | -1.25% | +64.25% | +114.23% | 55.19B | |
| +4.60% | +3.02% | +57.38% | +48.98% | 45.75B | |
| -1.44% | +0.39% | -14.68% | -17.33% | 22.98B | |
| -2.69% | -2.10% | -6.70% | +374.02% | 20.76B | |
| +3.22% | -0.84% | +27.88% | -20.46% | 16.26B | |
| +0.58% | +1.08% | +18.85% | -37.32% | 15.42B | |
| -1.01% | -2.30% | +28.59% | +174.08% | 13.05B | |
| +4.95% | +11.70% | +125.78% | +252.19% | 12.45B | |
| +3.07% | +0.14% | +29.05% | - | 12.37B | |
| Average | +0.79% | +2.23% | +36.71% | +111.05% | 23.8B | |
| Weighted average by Cap. | +1.49% | +1.48% | +40.78% | +101.14% |
Employees
-
